Unknown

Dataset Information

0

Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics.


ABSTRACT: Salvia miltiorrhiza Burge (Danshen) is an eminent medicinal herb that possesses broad cardiovascular and cerebrovascular protective actions and has been used in Asian countries for many centuries. Accumulating evidence suggests that Danshen and its components prevent vascular diseases, in particular, atherosclerosis and cardiac diseases, including myocardial infarction, myocardial ischemia/reperfusion injury, arrhythmia, cardiac hypertrophy and cardiac fibrosis. The published literature indicates that lipophilic constituents (tanshinone I, tanshinone IIa, tanshinone IIb, cryptotanshinone, dihydrotanshinone, etc) as well as hydrophilic constituents (danshensu, salvianolic acid A and B, protocatechuic aldehyde, etc) contribute to the cardiovascular protective actions of Danshen, suggesting a potential synergism among these constituents. Herein, we provide a systematic up-to-date review on the cardiovascular actions and therapeutic potential of major pharmacologically active constituents of Danshen. These bioactive compounds will serve as excellent drug candidates in small-molecule cardiovascular drug discovery. This article also provides a scientific rationale for understanding the traditional use of Danshen in cardiovascular therapeutics.

SUBMITTER: Li ZM 

PROVIDER: S-EPMC5943903 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics.

Li Zhuo-Ming ZM   Xu Suo-Wen SW   Liu Pei-Qing PQ  

Acta pharmacologica Sinica 20180426 5


Salvia miltiorrhiza Burge (Danshen) is an eminent medicinal herb that possesses broad cardiovascular and cerebrovascular protective actions and has been used in Asian countries for many centuries. Accumulating evidence suggests that Danshen and its components prevent vascular diseases, in particular, atherosclerosis and cardiac diseases, including myocardial infarction, myocardial ischemia/reperfusion injury, arrhythmia, cardiac hypertrophy and cardiac fibrosis. The published literature indicate  ...[more]

Similar Datasets

| S-EPMC4846759 | biostudies-literature
| S-EPMC4678694 | biostudies-literature
| S-EPMC6068259 | biostudies-literature
| S-EPMC2910010 | biostudies-literature
| S-EPMC4422947 | biostudies-literature
| S-EPMC7155419 | biostudies-literature
| S-EPMC7851637 | biostudies-literature
| S-EPMC4508048 | biostudies-literature
| S-EPMC10729661 | biostudies-literature
| S-EPMC5941821 | biostudies-literature